4.6 Article

Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients

Journal

NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 25, Issue 4, Pages 1279-1284

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfp655

Keywords

daptomycin; Gram-positive bacteria; haemodialysis; pharmacokinetics

Funding

  1. Cubist Pharmaceuticals, Inc
  2. Michigan Clinical Research Unit (MCRU)
  3. GCRC [M01-RR000042]
  4. National Center for Research Resources (NCRR) [UL 1 RR024986]
  5. National Center for Research Resources (NCRR)
  6. National Institutes of Health

Ask authors/readers for more resources

Background. Daptomycin has concentration-dependent antibacterial activity against Gram-positive bacteria. Its use is increasing in haemodialysis units. The manufacturer recommends a 4-6-mg/kg close administered every 48 hrs for patients receiving haemodialysis. However, there are no published data about daptomycin pharmacokinetics and clearance during haemodialysis. The recommended closing regimen would conflict with asymmetric thrice-weekly haemodialysis, which yields two similar to 44-hr and one similar to 68-hr interdialytic periods. This is the first study to evaluate daptomycin pharmacokinetics in haemodialysis patients, assess the extent of daptomycin dialytic removal and model serum concentrations at 44 and 68 hrs. Methods. Six otherwise healthy subjects on chronic haemodialysis (55.3 +/- 16.1 years old, three females, 66.2 +/- 14.2 kg) received a single 6-mg/kg dose of daptomycin post-haemodialysis infused over 30 minutes. Serial blood samples were collected for 44 hrs (pre-next haemodialysis) and throughout the subsequent haemodialysis session with a high permeability haemodialyser. Individual pharmacokinetic parameters determined by compartmental analysis were used to model trough serum concentrations at 44 and 68 hrs with 6-, 8- and 10-mg/kg post-haemodialysis doses. Results. The haemodialysis session in this trial yielded mean urea and daptomycin reduction ratios of 79.6 5.8% and 57.6 +/- 9.2%, respectively. Daptomycin half-life was 19.4 +/- 6.5 and 3.8 +/- 1.1 hrs 'off' and 'on haemodialysis', respectively, with minimal rebound 1 hr post-haemodialysis. All modelled trough concentrations at 44 and 68 hrs at all doses exceed typical minimum inhibitory concentration (MIC90) values for Staphylococcus. aureus and Enterococcus Conclusions. Daptomycin serum concentrations declined by 50% after a 4-hr haemodialysis session with a high permeability haemodialyser. A 6-mg/kg, iv. post-haemodialysis thrice-weekly dose should result in sufficient pre-haemodialysis daptomycin serum concentrations even after a 68-hr interdialytic period.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available